p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein

被引:47
作者
Chen, Ya-Wen [1 ]
Paliwal, Seerna [3 ]
Draheim, Kyle [1 ]
Grossman, Steven R. [3 ,4 ,5 ]
Lewis, Brian C. [1 ,2 ,5 ]
机构
[1] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA
[3] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA
[4] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA
[5] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01605 USA
关键词
D O I
10.1158/0008-5472.CAN-07-1960
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The INK4A/ARF tumor suppressor locus is frequently inactivated in hepatocellular carcinoma (HCC), yet the consequences of this remain unknown. We recently described a HCC mouse model in which loss of the Ink4a/Arf locus accelerates the development of metastasis and enhances tumor cell migration and invasion in cell culture assays. We show here that knockdown of p19Arf in an HCC cell line increases invasion in cell culture assays. Furthermore, reintroduction of p19(Arf) into HCC cell lines lacking Ink4a/Arf inhibits tumor cell invasion, without affecting cell proliferation, or cell transformation as measured by soft agar colony formation. Inhibition of cell invasion by p19(Arf) was dependent on its C-terminal binding protein (CtBP) interaction domain but independent of Mdm2 binding and nucleolar localization. Indeed, RNA interference-mediated knockdown of CtBP1 or CtBP2 decreased cell invasion, and ectopic expression of CtBP2 enhanced tumor cell migration and invasion. Thus, our data indicate a novel role for the Arf tumor suppressor protein in regulating phenotypes associated with tumor progression and metastasis in HCC cells.
引用
收藏
页码:476 / 482
页数:7
相关论文
共 38 条
[1]   CHD5 is a tumor suppressor at human 1p36 [J].
Bagchi, Anindya ;
Papazoglu, Cristian ;
Wu, Ying ;
Capurso, Daniel ;
Brodt, Michael ;
Francis, Dailia ;
Bredel, Markus ;
Vogel, Hannes ;
Mills, Alea A. .
CELL, 2007, 128 (03) :459-475
[2]   Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma [J].
Boissan, M ;
Wendum, D ;
Arnaud-Dabernat, S ;
Munier, A ;
Debray, M ;
Lascu, I ;
Daniel, JY ;
Lacombe, ML .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (11) :836-845
[3]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[4]   Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment [J].
Budhu, Anuradha ;
Forgues, Marshonna ;
Ye, Qing-Hai ;
Jia, Hu-Liong ;
He, Ping ;
Zanetti, Krista A. ;
Kammula, Udai S. ;
Chen, Yidong ;
Qin, Lun-Xiu ;
Tang, Zhao-You ;
Wang, Xin Wei .
CANCER CELL, 2006, 10 (02) :99-111
[5]   Genetic alterations in hepatoblastoma and hepatocellular carcinoma: Common and distinctive aspects [J].
Buendia, MA .
MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 39 (05) :530-535
[6]   Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells [J].
Chen, Ya-Wen ;
Klimstra, David S. ;
Mongeau, Nfichelle E. ;
Tatem, Jessica L. ;
Boyartchuk, Victor ;
Lewis, Brian C. .
CANCER RESEARCH, 2007, 67 (16) :7589-7596
[7]   CtBP, an unconventional transcriptional corepressor in development and oncogenesis [J].
Chinnadurai, G .
MOLECULAR CELL, 2002, 9 (02) :213-224
[8]   C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs [J].
Grooteclaes, M ;
Deveraux, Q ;
Hildebrand, J ;
Zhang, QH ;
Goodman, RH ;
Frisch, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) :4568-4573
[9]   Evidence for a function of CtBP in epithelial gene regulation and anoikis [J].
Grooteclaes, ML ;
Frisch, SM .
ONCOGENE, 2000, 19 (33) :3823-3828
[10]   Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion [J].
Guo, FK ;
Zheng, Y .
ONCOGENE, 2004, 23 (33) :5577-5585